Segmed has entered into a significant agreement with Bayer to integrate its advanced real-world imaging data (RWiD) solution into Bayer’s AI Innovation Platform (AIIP). This collaboration aims to provide healthcare organizations with the high-quality, diverse imaging data required to develop scalable AI-powered medical imaging applications. By offering real-world imaging data and cohort-building capabilities on Bayer’s cloud-based platform, the partnership is set to drive innovation in AI-powered healthcare solutions.
- The Role of Real-World Imaging Data in AI Development
- Medical imaging data makes up about 90% of healthcare data and is crucial for diagnosing and tracking diseases.
- Segmed’s platform provides access to millions of de-identified, real-world imaging studies linked to medical records, making it a valuable resource for developing AI tools in healthcare.
- Bayer’s AI Innovation Platform (AIIP)
- Bayer’s AIIP offers an end-to-end developer environment that supports the creation of AI-powered medical imaging products.
- The integration of Segmed’s imaging data into AIIP will make it easier for researchers and developers to access and utilize data for building scalable and compliant healthcare solutions.
- Benefits of the Collaboration
- Healthcare organizations, including academia, startups, and solution developers, will gain access to curated real-world medical imaging data, reducing the challenge of finding suitable data for AI tool development.
- This collaboration aims to support radiologists by improving diagnostic tools and increasing efficiency in the analysis of medical images, ultimately enhancing patient care.
- Impact on the Healthcare Ecosystem
- The combination of Segmed’s data and Bayer’s expertise in healthcare regulation promises to significantly advance patient outcomes by accelerating the development of AI tools that support radiologists.
- This partnership also has the potential to reduce costs and improve care delivery by automating and enhancing medical imaging workflows.
- Segmed’s Technology and Data Network
- Segmed’s platform is integrated with a vast network of healthcare partners, ensuring access to diverse, high-quality medical imaging data.
- The company’s focus on de-identified imaging data ensures compliance with privacy regulations, making it easier for organizations to utilize the data without compromising patient confidentiality.
The partnership between Segmed and Bayer represents a major step forward in the development of AI-powered healthcare solutions. By integrating Segmed’s real-world imaging data into Bayer’s AI Innovation Platform, the collaboration will empower healthcare organizations to build scalable, compliant AI tools that improve the efficiency and accuracy of medical imaging processes. This joint effort has the potential to revolutionize the healthcare ecosystem by supporting radiologists, advancing patient outcomes, and accelerating innovation in the medical field.